Tuesday, 22 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14467
Articles
Company
Medical Device
Artech Medical’s Balloon Cryoablation Catheter Wins NMPA Nod for Atrial Fibrillation Treatment
October 13, 2024
Hospital
Former Hainan Medical University President Li Jingquan Expelled for Serious Disciplinary Violations
October 13, 2024
Company
Drug
Pfizer’s RSV Vaccine Abrysvo Shows Strong Protection in Immunocompromised Adults, Phase III Sub-Study Reveals
October 13, 2024
Company
Deals
TYK Medicines Inc. Targets HKD 506.3 Million in Hong Kong IPO for Drug Pipeline Expansion
October 13, 2024
Company
Drug
Chinese NMPA Approves Hengrui Pharmaceuticals’ Generic Abraxane for Metastatic Pancreatic Cancer Treatment
December 3, 2024
Company
Deals
Mindray Medical Forges Comprehensive Partnership with CUHK-Shenzhen School of Medicine
October 13, 2024
Company
Drug
CSPC Pharmaceutical’s SYS6020 Receives NMPA Approval for Clinical Trials in Systemic Lupus Erythematosus
October 13, 2024
Company
Drug
Mabwell’s Nectin-4 Targeting ADC 9MW2821 on Path to Breakthrough Designation in China for Urothelial Carcinoma
October 13, 2024
Company
Deals
Shineyo Medical Secures RMB 100 Million in Series A+ Funding for Cardiac and Vascular Devices
October 13, 2024
Company
Drug
Fujian Cosunter’s Innovative Drug GST-HG141 Exceeds Efficacy in Reducing HBV DNA in Phase II Study
October 13, 2024
Company
Drug
3SBio Subsidiary Achieves Milestone in Phase III Psoriasis Trial with SSGJ-608
October 13, 2024
Company
Drug
Guangdong Zhongsheng Pharmaceutical’s COVID-19 Drug Leritrelvir Approved in Macau
October 13, 2024
1
2
…
621
622
623
624
625
…
1,205
1,206
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?